Misleading Media Coverage Of Medicine

Media coverage of clinical trials does not contain the elements readers require to make informed decisions. A comparison of the coverage received by pharmaceutical and herbal remedy trials, reported in the open access journal BMC Medicine, has revealed that it is rarely possible for the lay public to assess the credibility of the described research.

Compugen And Merck Serono To Collaborate On Novel Peptide For The Treatment Of Inflammatory Diseases

Compugen Ltd. (NASDAQ:CGEN) announced today that it has signed a collaboration agreement with Merck KGaA, acting for its pharmaceutical division Merck Serono, covering CGEN-855, a Compugen-discovered novel peptide targeting the FPRL1 G-protein coupled receptor (GPCR). This peptide has demonstrated, in recently completed initial in vitro and in vivo studies, the potential to treat, among other [...]

Testing, Immediately Treating HIV/AIDS Cases In Africa Could Halt Epidemic, Model Predicts

Testing all adults annually for HIV and immediately treating every person who tests positive “could virtually end the AIDS epidemic in Africa in about a decade,” according to a mathematical model published Wednesday in the journal Lancet, the Washington Post reports.

Parents of new babies should be considered for a whooping cough booster, say experts

A booster vaccination for parents of new babies and other household members may be the most effective way of preventing the fatal form of whooping cough in young infants, say a group of paediatric intensive care doctors on bmj.com today.

Researchers Identify Genomic Causes of a Certain Type of Leukemia Relapse

Scientists at St. Jude Children’s Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse.

Research identifies cell receptor as target for anti-inflammatory immune response

Cell reception. By comparing normal mice (left) with mice that are genetically engineered to lack certain receptors in their spleen (right), scientists have shown SIGNR1 receptors (blue) are required to facilitate an anti-inflammatory action.

St. Jude identifies genomic causes of a certain type of leukemia relapse

Scientists at St. Jude Children’s Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse.

Study identifies genetic variants giving rise to differences in metabolism

Common genetic polymorphisms induce major differentiations in the metabolic make-up of the human population, according to a paper published November 28 in the open-access journal PLoS Genetics.

A novel target for therapeutics against Staph infection

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation protein fibrinogen to cause methicillin-resistant Staphylococcus aureus (MRSA) infections, a finding that could aid in developing therapeutics against the potentially deadly disease.

CSHL scientists discover a new way in which epigenetic information is inherited

Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling to it.